Skip to main content
Market intelligence
IMVTHealthcare

Immunovant Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 20, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 20, 2026Melanie GloriaChief Operating OfficerSale3,056$44.16$134,953
Jul 24, 2026Atul PandeCorporate insiderSale1,500$39.80$59,700
Jul 23, 2026Jay S StoutChief Technology OfficerSale2,857$38.69$110,537